Search

everythinglearnresearchcommunity

for

Search:↓

There's no significant link between hair loss from male pattern baldness and early heart disease.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

High-frequency ultrasound can effectively visualize and assess hair loss.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Botulinum toxin treatment improves hair follicle width and length in androgenetic alopecia.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Trichoscopy and pathological examination both have unique benefits and cannot completely replace each other in evaluating hair.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

Balding and low testosterone increase risk of urinary stones.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Healthy Han Chinese have lower hair density than whites and Africans, and transplanting 300 hair units can nearly restore normal hair density.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.

People with androgenetic alopecia (AGA) have lower hair density and more single-hair units compared to those with normal scalps.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Hair loss in men (androgenetic alopecia) is significantly linked to decreased scalp sensitivity, but not temperature sensitivity. More research is needed to confirm this. Comparing this hair loss to leprosy is unsupported and stigmatizing.

Male hair loss is mainly due to thinner hair, not less hair.

Oral minoxidil is as effective as topical minoxidil for male hair loss but has more side effects like excessive hair growth and headaches.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

N-acetyl-cysteine improves hair growth and is safe for treating early male hair loss.

Men with early-onset baldness may have a higher risk of heart disease.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.